Search

everythinglearnresearchcommunity

for

Search:↓

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

A document listed serious side effects from various drugs, including deaths and diseases, emphasizing the importance of being aware of drug side effects.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Diphenyl cresyl phosphate has low toxicity but can harm the liver, kidneys, adrenal glands, and testicles at high doses.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Licorice root-derived nanoparticles target liver cancer cells to improve treatment and reduce side effects.

Avacopan is generally safe, with some minor side effects like nausea and fatigue.

Valproic acid can cause weight gain and hair texture changes.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Cucurbita maxima seed extract shows promise for breast cancer treatment.

TPA is about 50 times more effective at promoting tumors than MZ.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Valproic acid effectively reduces aggressive and impulsive behaviors in brain injury patients with acceptable side effects.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Mitotane changes steroid breakdown, affecting cortisol availability.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.